Kidney Transplant Clinical Trials in Chicago, Illinois

3 studies are recruiting for kidney transplant in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Advancing Transplantation Outcomes in Children

    This is a pediatric kidney transplant study comparing the safety and efficacy of an immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil (MMF). Two hundred participants will be randomized (1:1) to one of two groups within 24 hours following the transplant pr…

    Stage
    Phase 2
    Ages
    13 to 20
    Site
    Ann and Robert H. Lurie Children's Hospital of Chicago (Site #: 71016), Chicago, Illinois
    Locations
    21 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)
  2. Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

    The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Chicago, Illinois
    Locations
    130 in total
    Run by
    Alexion Pharmaceuticals, Inc.
  3. Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

    The purpose of this study is to find out if Berinert can improve kidney function in the first year after transplant and to find out what effects, good or bad, Berinert will have in the kidney recipient. This research study will compare Berinert to placebo. The placebo looks exactly like Berinert bu…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Northwestern Memorial Hospital, Chicago, Illinois
    Locations
    4 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.